4.6 Article

Ex vivo evaluation of antifibrotic compounds in skin scarring: EGCG and silencing of PAI-1 independently inhibit growth and induce keloid shrinkage

Related references

Note: Only part of the references are listed.
Review Dermatology

Long-term organ culture of keloid disease tissue

Rania Bagabir et al.

EXPERIMENTAL DERMATOLOGY (2012)

Review Oncology

Cancer and metastasis: prevention and treatment by green tea

Naghma Khan et al.

CANCER AND METASTASIS REVIEWS (2010)

Review Cell Biology

Molecular dissection of abnormal wound healing processes resulting in keloid disease

Barbara Shih et al.

WOUND REPAIR AND REGENERATION (2010)

Article Dermatology

Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways

Joan C. Smith et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)

Article Biochemistry & Molecular Biology

Gene silencing in a human organotypic skin model

Michael Mildner et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Food Science & Technology

Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: Genotoxicity

R. A. Isbrucker et al.

FOOD AND CHEMICAL TOXICOLOGY (2006)

Article Food Science & Technology

Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies

R. A. Isbrucker et al.

FOOD AND CHEMICAL TOXICOLOGY (2006)

Article Dermatology

The human hair follicle immune system:: cellular composition and immune privilege

T Christoph et al.

BRITISH JOURNAL OF DERMATOLOGY (2000)